s.lindholm
Submits third-party assay reports on material purchased directly. Based in Aalborg.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.60%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043081 | Tirzepatide | KP | KP-2605-E6030 | VendorInvestigate | 2026-Q2 | 97.55 | 4.21 | 91.4 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042233 | N-Acetyl Semax Amide | Homopeptide | HOMO-2603-C1382 | Janoshik | 2026-Q2 | 99.74 | 8.09 | 93.9 | Supplier-supplied | 0 | PASS |
| AX-2026-043558 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | PeptideMeter | 2026-Q1 | 97.63 | 3.64 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019044 | GHRP-2 | JEEP | JEEP-2508-S3268 | Janoshik | 2025-Q4 | 99.85 | 3.33 | 107.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021113 | TB-500 | WXT | WXT-2507-J5534 | Janoshik | 2025-Q4 | 97.75 | 3.86 | 100.6 | Buyer-sourced | 2 | FAIL |
| AX-2025-020730 | Tirzepatide | SGN | SGN-2506-J8941 | Janoshik | 2025-Q3 | 97.16 | 2.15 | 101.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-018661 | CJC-1295 (no DAC) | QYB | QYB-2505-C5547 | Janoshik | 2025-Q3 | 98.60 | 5.58 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020455 | Liraglutide | KP | KP-2502-E5076 | Medutest | 2025-Q1 | 98.70 | 7.43 | — | Laboratory-retained | 0 | PASS |
| AX-2024-004743 | GHRP-6 | Homopeptide | HOMO-2407-T9333 | Janoshik | 2024-Q3 | 99.93 | 6.41 | 89.5 | Supplier-supplied | 1 | MARGINAL |